ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

December 31, 2004

M.D. Anderson signs collaboration agreement with Institut Gustave Roussy.

February 13, 2004

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

PET Three Months After Therapy Provides Early Warning Of Need For Intervention

November 30, 2007

Smokers Who Quit Live Longer Than Those Who Spit-Study

May 25, 2007

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002